A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)

NCT03267732 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Subjects

Interventions

BIOLOGICAL: Pegilodecakin

Sponsor

Eli Lilly and Company

Collaborators

[object Object]